Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Derivative Control
2-Fluorophenyl cyclopentyl ketone is a key intermediate in the synthesis of fluoroketamine, targeting NMDA receptor modulation. This compound demonstrates significant potential for research in pharmacological applications, particularly in the study of anesthetic and analgesic effects. Its role as a drug derivative control aids in the exploration of synthetic routes and the development of novel therapeutic agents. -
Drug Derivative
5-Methyluridine 5'-monophosphate is a nucleotide derivative of 5-Methyluridine that serves as a valuable chemical building block in nucleic acid research. It is primarily utilized in studies involving RNA modification and the investigation of cellular mechanisms related to RNA metabolism. This compound supports applications in drug design and the development of therapeutic agents. -
Drug Derivative Control
Ticagrelor EP Impurity E hydrochloride is a conformationally restricted phenethylamine derivative primarily used for drug derivative control. It serves as an important standard in the quality assessment of Ticagrelor, facilitating the evaluation of impurities during pharmaceutical development and analytical testing. Its role in ensuring drug safety and efficacy makes it essential for regulatory compliance in the production of antiplatelet therapies. -
Drug Derivative
Val-CDCA is a conjugate of chenodeoxycholate (CDCA) and C-24 L-Valine, primarily targeting the sodium-taurocholate cotransporting polypeptide (NTCP). This compound effectively inhibits taurocholate uptake in human NTCP-stably transfected HEK293 cells, indicating its potential utility in research related to hepatitis B virus (HBV) infection. Val-CDCA serves as a valuable tool for studies investigating bile acid transport and its implications in liver diseases. -
Drug Derivative
Sovaprevir is a drug derivative that acts as a non-structural protein 3 (NS3) serine protease inhibitor. It exhibits antiviral activity, particularly against hepatitis C virus (HCV), by preventing viral replication. This compound is primarily utilized in antiviral research and development, enhancing the understanding of HCV treatment strategies. -
Drug Derivative
Indanazoline is a drug derivative that acts primarily as a selective vasoconstrictor. It exhibits significant vasoconstrictive activity through its interactions with adrenergic receptors, making it valuable in cardiovascular research. This compound can be utilized in studies focusing on blood pressure regulation and vascular dynamics, contributing to the understanding of hypertensive conditions and related pharmacological treatments. -
Drug Derivative
2-Amino-1-(3-chlorophenyl)-1-propanone hydrochloride acts as a drug derivative, primarily influencing neurotransmitter systems. This compound has been studied for its potential role in the synthesis of various pharmaceutical agents and may exhibit biological activities related to central nervous system modulation. Its applications in chemical research include the development of new therapeutic candidates targeting mood disorders and other neurological conditions. -
Drug Derivative
Cyclamen homoaldehyde is a synthetic chemical compound primarily utilized as a drug derivative. This reagent exhibits significant olfactory properties, contributing floral, lily-of-the-valley, and fresh green scents to perfumery formulations. Its unique fragrance profile supports applications in fragrance development and formulation research within the cosmetic and personal care industries. -
Drug Derivative
4-Bromoethcathinone hydrochloride is a drug derivative that acts primarily as a stimulant. It is known to exhibit significant dopaminergic activity, making it relevant for research into central nervous system disorders and substance use behaviors. This compound may be employed in studies focusing on drug metabolism, neuropharmacology, and pharmacodynamics. -
Drug Derivative
GV196771 is a drug derivative known for its ability to modulate specific biological pathways. This compound exhibits significant biological activity relevant to various research applications, including pharmacological studies and drug development. Its efficacy in cellular contexts makes GV196771 a valuable tool for exploring therapeutic mechanisms and enhancing drug efficacy. -
Drug Derivative
(Rac)-L-826141 is a drug derivative that functions as a selective inhibitor of specific biological pathways. It exhibits significant activity against target proteins involved in disease processes, making it a valuable tool for understanding drug mechanisms and potential therapeutic interventions. This compound is suitable for various research applications, including pharmacological studies and mechanism of action investigations. -
Drug Derivative
CH-38083 is a drug derivative with potential applications in pharmacological research. This active compound exhibits biological activity that may contribute to understanding the efficacy of therapeutic agents and their mechanisms of action. Researchers can utilize CH-38083 in studies related to drug metabolism and pharmacokinetics, providing insights into the development of novel pharmaceuticals. -
Drug Derivative
N-Ethyl Tadalafil, a derivative of Tadalafil, primarily acts as a phosphodiesterase type 5 (PDE5) inhibitor. It enhances nitric oxide-mediated vasodilation, contributing to its efficacy in treating erectile dysfunction and pulmonary hypertension. This compound is valuable for research applications focusing on erectile function, cardiovascular health, and related pharmacological studies. -
Drug Derivative
(±)10(11)-EDP ethanolamide (10,11-EDP-EA) is an ω-3 endocannabinoid epoxide derivative that demonstrates significant antiangiogenic and antitumor effects. It also exhibits anti-migratory properties in osteosarcoma models, making it a valuable tool for cancer research. This compound is applicable in studies focusing on the mechanisms of tumor growth and metastasis, as well as potential therapeutic approaches targeting endocannabinoid pathways. -
Drug Derivative
Descarbamylnovobiocin is a derivative of the antibiotic Novobiocin, primarily targeting bacterial DNA gyrase. This compound exhibits antibacterial activity and is utilized in research focused on understanding DNA replication and repair mechanisms in bacterial systems. Its application extends to studies investigating antibiotic resistance and the development of new antimicrobial agents. -
Drug Derivative
Perthane is a drug derivative known for its biological activity in modulating various cellular processes. It has been studied for its potential applications in pharmaceutical research, particularly in drug development and optimization. Its unique properties make it a valuable tool for investigating therapeutic mechanisms and enhancing drug efficacy. -
Drug Derivative
Lenampicillin is a penicillin derivative that exerts its antibacterial effects by inhibiting bacterial cell wall synthesis. It is effective against a variety of gram-positive and some gram-negative bacteria, making it a valuable tool in microbiological studies and antibiotic resistance research. Its biochemical properties facilitate investigations into drug efficacy, combination therapies, and the mechanisms of bacterial resistance. -
Drug Derivative
1β-OH Glycine DCA is a bile acid derivative that serves as a drug derivative. It exhibits key biological activities that may influence metabolic pathways and cellular signaling, making it an important compound for research. This reagent is suitable for studies focused on bile acid metabolism, potential therapeutic applications, and the investigation of related biological processes. -
Drug Derivative
3',4'-Dimethyl-α-pyrrolidinovalerophenone hydrochloride is a drug derivative targeting the central nervous system. It exhibits stimulant properties and is often utilized in research related to neuropharmacology and the study of psychostimulant effects. This compound may be valuable for investigations into behavioral pharmacology and the mechanisms underlying drug addiction. -
Drug Derivative
BPP is a drug derivative known for its bioactive properties. This compound exhibits potential efficacy in various biological systems, making it a valuable tool for pharmaceutical research and drug development. BPP is utilized in investigations aimed at understanding drug mechanisms and enhancing therapeutic approaches. -
Drug Derivative
2α,17α-Diethynyl-A-nor-5α-androstane-2β,17β-diol diacetate is a synthetic derivative targeting various biological pathways. This compound exhibits significant activity in modulating hormonal and metabolic processes, making it a valuable tool in endocrinology and pharmacological research. Investigators utilize it for studies related to steroid signaling and its implications in disease models. -
Drug Derivative
SB-235699 is a selective inhibitor of the monoacylglycerol lipase (MAGL) enzyme, which plays a crucial role in the endocannabinoid system by regulating the degradation of 2-arachidonoylglycerol. This compound exhibits anti-inflammatory and analgesic properties and has been utilized in research to explore its potential therapeutic effects in pain management and neuroprotection. Its efficacy in modulating cannabinoid signaling makes it a valuable tool for studies in pharmacology and neurobiology. -
Drug Derivative
Hexadesacetyleuomynine is a nitrogen-containing dihydroagarofuran derivative extracted from the dried roots of Tripterygium wilfordii. This compound exhibits significant biological activity, particularly in modulating immune responses and exhibiting anti-inflammatory properties. It is primarily used in pharmacological research focused on autoimmune disorders and inflammation-related studies. -
Drug Derivative
N-Nitroso desloratadine is a nitrosamine derivative of desloratadine, primarily targeting histamine H1 receptors. This compound exhibits antihistaminic activity and is being investigated for its potential effects on allergic responses and inflammatory processes. Its role in pharmacological studies enhances the understanding of drug metabolism and safety profiles in chemical research. -
Drug Derivative
Qinanone G is a derivative of 2-(2-phenylethyl)chromone, derived from the high-quality Chinese agarwood 'Qi-Nan' sourced from Aquilaria sinensis (Lour.) Glig. This compound exhibits no inhibitory activity against acetylcholinesterase (AChE) or cancer cell lines, making it a unique candidate for further exploration in pharmacological and botanical research applications. Its distinctive profile may contribute to studies focused on the bioactivity of natural products. -
Drug Derivative
SMP-797 hydrochloride is a drug derivative known for its potential as a therapeutic agent. This compound exhibits significant biological activity that may be leveraged in various pharmacological research applications. Its mechanism of action and efficacy in modulating specific biological pathways make it a valuable reagent for studies focused on drug development and optimization. -
Drug Derivative
Oxametacin is a derivative of the nonsteroidal anti-inflammatory drug (NSAID) class. It primarily inhibits cyclooxygenase (COX) enzymes, leading to a reduction in prostaglandin synthesis, which is responsible for pain and inflammation. This compound is utilized in research to explore its anti-inflammatory properties and evaluate potential therapeutic effects in various inflammatory conditions. Its efficacy in modulating pain response makes it relevant for studies in pain management and chronic inflammatory disorders. -
Drug Derivative
Leucinocaine is a drug derivative that acts as a local anesthetic by inhibiting sodium channel activity, thereby blocking nerve impulse conduction. Its primary biological activity involves pain relief in localized areas, making it useful for various clinical and research applications in pain management and anesthetic studies. This compound can also serve as a valuable tool in neuropharmacological research and the development of new analgesic agents. -
Drug Derivative
Sunepitron is a drug derivative that primarily functions as a selective serotonin reuptake inhibitor (SSRI). It demonstrates key biological activity by enhancing serotonin levels in the synaptic cleft, making it valuable for studying mood disorders and depression-related pathways. This compound serves as a pivotal tool in pharmacological research focused on neuropsychiatric conditions and the modulation of serotonergic signaling. -
Drug Derivative
6-epi-Lipoxin A4 is a potent derivative of lipoxin A4, primarily targeting inflammatory pathways. It exhibits significant anti-inflammatory activity by promoting the resolution of inflammation, making it a valuable tool for studying inflammatory diseases. This compound is widely used in research focused on mechanisms of inflammation, immune response modulation, and potential therapeutic applications in chronic inflammatory conditions. -
Drug Derivative
AHR-11797 is a drug derivative that functions as a potent antagonist of the aryl hydrocarbon receptor (AHR). This compound demonstrates significant inhibition of AHR-mediated signaling pathways, making it valuable for research involving environmental toxicity and immune regulation. AHR-11797 is primarily utilized in studies exploring the roles of AHR in cancer biology, inflammation, and developmental processes. -
Drug Derivative
GSK3-IN-6 is a potent inhibitor of glycogen synthase kinase 3 (GSK3), a critical enzyme involved in various signaling pathways. This compound exhibits significant biological activity by modulating GSK3 activity, which has implications in neuronal function, metabolism, and cancer research. GSK3-IN-6 is primarily utilized in studies investigating cellular signaling, therapeutic strategies for neurological disorders, and cancer treatment. -
Drug Derivative
Dimefuron is a drug derivative that functions primarily as an antifungal agent. It exhibits significant biological activity against a range of fungal pathogens, making it a valuable tool in antifungal research and drug development. Researchers can utilize Dimefuron to explore mechanisms of action and to investigate therapeutic strategies for fungal infections. -
Drug Derivative
Metesind is a drug derivative that primarily functions as a pharmacological agent. It exhibits significant biological activity that makes it relevant for a variety of research applications, including drug development and biochemical studies. Its unique properties enable investigations into therapeutic mechanisms and efficacy within various biological systems. -
Drug Derivative
3-Hydroxy carvedilol is a pharmacologically active derivative of carvedilol, primarily acting as a non-selective beta-blocker and alpha-1 blocker. It exhibits significant cardiovascular effects, including antihypertensive and antianginal properties, making it relevant for studies on cardiovascular diseases. Research applications include the evaluation of its potential in modulating blood pressure and heart rate, as well as its role in vascular function and cardiac protection. -
Drug Derivative
5-HT4 antagonist 3 is a selective antagonist of the 5-HT4 serotonin receptor, primarily involved in neurotransmission modulation. This compound has demonstrated significant potential in research applications related to neuropharmacology, particularly in studying cognitive function and gastrointestinal motility. Its ability to inhibit 5-HT4 receptor activity makes it a valuable tool for elucidating receptor signaling pathways and developing therapeutic strategies for related disorders. -
Drug Derivative
Deacetylsaptomycin D is a deacetylated derivative of saptomycin that exhibits in vitro antitumor activity. It has been shown to effectively inhibit the proliferation of mouse methoxy-A fibrosarcoma cells. This compound is of interest for research applications focused on cancer biology and the exploration of novel therapeutic agents in oncology. -
Drug Derivative
A28695B is a drug derivative that demonstrates notable pharmacological activity through its targeted interaction with specific cellular pathways. This compound is utilized in research applications aimed at investigating drug metabolism, efficacy, and potential therapeutic effects. A28695B can provide critical insights into the development of new therapeutic agents by serving as a valuable tool for drug discovery and biochemical studies. -
Drug Derivative
3'-epi-Paclitaxel is a derivative of the antineoplastic agent Paclitaxel, primarily targeting microtubules to disrupt cell division. This compound exhibits significant cytotoxic activity against various cancer cell lines and is useful in studying paclitaxel-related mechanisms of action and resistance. Its applications include cancer research, particularly in investigating therapeutic efficacy and developing combination therapies. -
Drug Derivative
Anticancer agent 261 is a novel drug derivative specifically designed to target cancer cell proliferation. This compound exhibits significant cytotoxicity across various cancer cell lines, making it a valuable tool for investigating anti-tumor mechanisms. Its applications extend to studying the molecular pathways involved in tumor growth and resistance, thereby contributing to the development of more effective cancer therapies. -
Drug Derivative
FR217840 is a novel drug derivative known for its active compound properties. It exhibits significant biological activity, making it valuable in pharmaceutical research and development. This compound is utilized in studies focused on drug design and optimization, contributing to the advancement of therapeutic agents. -
Drug Derivative
RY 024 is a potent drug derivative known for its ability to modulate biological pathways. It exhibits significant activity in cancer research by targeting specific signaling cascades involved in tumor progression. This compound is primarily utilized in studies aimed at elucidating mechanisms of drug resistance and enhancing therapeutic efficacy in oncology. -
Drug Derivative
Clocoumarol is a drug derivative that functions as an anticoagulant through the inhibition of vitamin K epoxide reductase. This compound exhibits significant biological activity in the prevention of thrombosis and is utilized in research applications related to cardiovascular diseases and coagulation disorders. Its mechanism of action makes it relevant for studies focused on blood coagulation pathways and the development of novel anticoagulant therapies. -
Drug Derivative
M-5MPEP is a potent metabotropic glutamate receptor 5 (mGluR5) antagonist. It exhibits significant neuroprotective effects and is utilized in research focused on neurological disorders, such as anxiety and depression. This compound provides valuable insights into the modulation of glutamate signaling pathways, making it an important tool for studying synaptic transmission and neuropharmacology. -
Drug Derivative
ICI 200355 is a potent drug derivative that acts as a selective estrogen receptor modulator (SERM). It demonstrates significant biological activity in modulating estrogenic effects and is primarily utilized in research focused on hormone-related disorders and cancer therapy. This compound serves as an important tool in studying the mechanisms of estrogen receptor signaling and therapeutic approaches for estrogen-dependent tumors. -
Drug Derivative
R-18893 is a potent drug derivative that acts predominantly as an inhibitor of specific biological pathways relevant to various therapeutic areas. This compound exhibits key biological activities that can be leveraged in research applications focused on drug development and pharmacological studies. Its mechanistic profile supports investigations into metabolic modulation and disease-targeted therapies, making it a valuable tool for researchers in life sciences. -
Drug Derivative
TAK 187 is a drug derivative that exhibits potent activity as a selective modulator in targeted therapeutic applications. This compound has been shown to influence key biological pathways, making it relevant for research focused on drug development and pathway elucidation in various disease models. Its unique mechanism of action offers promising insights for investigating therapeutic strategies in complex biological systems. -
Drug Derivative
LLP6 is a drug derivative that acts as a potent inhibitor of various signaling pathways involved in cellular processes. It has demonstrated significant biological activity in modulating cellular responses, making it a valuable tool for researchers investigating disease mechanisms. LLP6 is particularly applicable in studies focused on cancer biology and therapeutic development. -
Drug Derivative
RU 25434 is a drug derivative that acts as a modulator of specific signaling pathways. This compound has demonstrated significant biological activity in various in vitro studies, making it a valuable tool for researchers investigating cellular responses related to drug mechanisms. RU 25434 is primarily utilized in pharmacological research to explore its therapeutic potential and effects on disease models. -
Drug Derivative
SR-4326 is a drug derivative that functions as a potent inhibitor of specific molecular targets involved in various cellular processes. This compound exhibits significant biological activity and has applications in pharmacological research, particularly in the study of disease mechanisms and the development of novel therapeutic strategies. Its efficacy in modulating target pathways makes it a valuable tool for investigating drug effects and biological phenomena in diverse cell models.
